Detalhe da pesquisa
1.
Factors Associated with Increased or Decreased Stress Level in French Children during the First COVID-19 Lockdown.
Int J Environ Res Public Health;
20(5)2023 03 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36901677
2.
A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.
Hum Vaccin;
6(10): 841-8, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20930559
3.
Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials.
Hum Vaccin;
6(4): 336-45, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20372083
4.
Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial.
Hum Vaccin;
6(4): 346-54, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20372053
5.
Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.
BMC Med;
7: 13, 2009 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19341446
6.
Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
J Travel Med;
12(6): 319-26, 2005.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16343383
7.
Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.
Hum Vaccin Immunother;
9(1): 115-21, 2013 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23442585
8.
Immunogenicity and safety of Intanza(®)/IDflu(®) intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial.
Hum Vaccin Immunother;
9(9): 1971-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23778938
9.
Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey.
Adv Ther;
29(1): 41-52, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22228256
10.
Acceptance of Intanza® 9 µg intradermal influenza vaccine in routine clinical practice in Australia and Argentina.
Adv Ther;
28(8): 640-9, 2011 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21751080
11.
Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
Vaccine;
28(42): 6885-90, 2010 Oct 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20709000
12.
Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
Vaccine;
27(52): 7304-12, 2009 Dec 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19849996
13.
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
Vaccine;
26(51): 6614-9, 2008 Dec 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18930093
14.
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
J Infect Dis;
198(5): 650-8, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18652550
15.
Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
Vaccine;
23(44): 5144-8, 2005 Oct 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16043271
16.
A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults.
Vaccine;
21(32): 4650-4, 2003 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14585671
17.
Immunogenicity and safety of two doses of a paediatric hepatitis A vaccine in thai children: comparison of three vaccination schedules.
J Trop Pediatr;
49(6): 333-9, 2003 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14725410
18.
Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
Vaccine;
23(1): 29-35, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15519704